Showing results (181-190 of 342) with videos related to

Sort By:
Pageof 35
Biochemical Pharmacology|September 15, 1988
Effects of methamphetamine on central monoaminergic systems in normal and ascorbic acid-deficient guinea pigsL A Matsuda, C J Schmidt, J W Gibb, et al.
Drug and Alcohol Dependence|February 1, 1995
The role of NMDA receptor systems in neuropeptide responses to stimulants of abuseG R Hanson, N Singh, K Merchant, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatmentJ K Ritter, C J Schmidt, J W Gibb, et al.
European Journal of Pharmacology|September 9, 1986
Response of mesolimbic substance P systems to methamphetamine treatmentG R Hanson, J K Ritter, C J Schmidt, et al.
Brain Research|December 5, 1994
Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activityJ D Wagstaff, L G Bush, J W Gibb, et al.
European Journal of Pharmacology|August 22, 1986
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brainD M Stone, D C Stahl, G R Hanson, et al.
Neuropharmacology|March 1, 1986
Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in ratL A Matsuda, C J Schmidt, G R Hanson, et al.
Neuropharmacology|December 1, 1987
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of ratD M Stone, K M Merchant, G R Hanson, et al.
Brain Research|January 1, 1987
Ascorbic acid-deficient condition alters central effects of methamphetamineL A Matsuda, C J Schmidt, J W Gibb, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Role of endogenous dopamine in the neurochemical deficits induced by methcathinoneM P Gygi, A E Fleckenstein, J W Gibb, et al.
Pageof 35